Financial Engines Advisors
AGN

Financial Engines Advisors’s Allergan Inc AGN Stock Holding History

Financial Engines Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-35,697
Closed -$7.59M – 55
2014
Q4 		$7.59M Sell
35,697
-7,604
-18% -$1.51M 6.47% 5
2014
Q3 		$7.72M Buy
43,301
+1,115
+3% +$185K 5.95% 5
2014
Q2 		$7.14M Sell
42,186
-15,172
-26% -$2.36M 6.13% 5
2014
Q1 		$7.12M Buy
57,358
+2,618
+5% +$319K 5.82% 5
2013
Q4 		$6.08M Sell
54,740
-5,550
-9% -$530K 5.06% 5
2013
Q3 		$5.45M Buy
60,290
+3,293
+6% +$296K 4.54% 5
2013
Q2 		$4.8M Buy
+56,997
New +$5.91M 4.13% 4

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Financial Engines Advisors's AGN Position: Q1 2015 in Review

Financial Engines Advisors sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 35,697 shares — an estimated $7.59M sold.

Financial Engines Advisors first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $7.72M in Q3 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Financial Engines Advisors reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Financial Engines Advisors sold 35,697 Allergan Inc shares in Q1 2015, an estimated $7.59M.
  • Financial Engines Advisors first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Financial Engines Advisors's Allergan Inc position peaked at $7.72M in Q3 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Financial Engines Advisors's 13F filing for Q1 2015, filed 6 May 2015.